Sara Stapleton, L.Ac., MS, MAOM
You got your labs back. Everything is "normal." But you still feel exhausted, foggy, and off — and your doctor is telling you there's nothing wrong.
I hear this constantly. And it's not a mystery once you understand how standard lab ranges are actually built.
Most reference ranges are established by testing a population of apparently healthy subjects and defining "in range" as the middle 95th percentile of that distribution.1 The top and bottom 2.5% get flagged as abnormal. Everyone else is "normal" — by math, not by physiology. A result can sit comfortably within that range and still not reflect adequate function for your body, your symptoms, or your long-term risk profile.
What "normal" actually means on your lab report: Your result falls within the middle portion of values observed in a reference population. It does not mean your body is functioning at its best — or that your symptoms don't have a biochemical explanation.
Functional interpretation doesn't mean ordering a completely different set of tests. It means reading familiar tests with a different question: is this result consistent with how this patient actually feels, and does it reflect adequate function — or just statistical normalcy? That requires time and clinical context that a standard lab review rarely includes.
Here's where the gap shows up most often.
Thyroid Function: TSH
Most labs use a TSH reference range of roughly 0.5 to 4.5 mIU/L. That's a wide band — wide by design, because it was built to capture the statistical middle of a large, varied population. A regional study establishing TSH reference intervals for a healthy Chinese population found sex-specific ranges within this same general territory (0.64–4.05 mIU/L in men, 0.72–5.66 mIU/L in women), illustrating how much a "normal" range can shift by population and lab.2
What matters clinically isn't just whether a value clears the cutoff. A TSH trending toward the upper end of normal is not the same physiological picture as one sitting in the middle — particularly when fatigue, cold sensitivity, brain fog, hair changes, and mood shifts are present. Those symptoms can appear before a TSH crosses any diagnostic threshold.
A high-normal TSH doesn't automatically require treatment. It means the number doesn't get to stand alone. Symptoms, history, and the full thyroid panel — Free T3, Free T4, antibodies — are all part of the picture.
Blood Sugar: Fasting Glucose and HbA1c
Standard medicine defines prediabetes as a fasting glucose of 100–125 mg/dL or an HbA1c of 5.7–6.4%. Those cutoffs are meaningful diagnostic thresholds. But the research on risk doesn't wait neatly for those numbers to be crossed.
A 2024 review documented that prediabetes — even before a formal diagnosis — is associated with increased cardiovascular risk, nephropathy, neuropathy, and retinopathy.3 Separately, a retrospective study of cardiac surgery patients found that HbA1c values above 5.9% were associated with significantly elevated risk of acute kidney injury and atherosclerotic vascular disease, even in patients not yet classified as diabetic.4
A functional approach pays attention to glucose patterns earlier — not to over-diagnose, but to intervene before the trajectory becomes harder to reverse.
Ferritin: Iron Stores
This is where standard ranges most consistently fail active, high-achieving women.
For adult women, standard ferritin reference ranges commonly run from roughly 15 to 150 µg/L — though exact intervals vary meaningfully by lab, testing methodology, age, and menopausal status. The lower boundary is where most of the functional gap shows up. But iron deficiency without anemia is a real and well-documented clinical entity. Symptomatic patients experiencing fatigue, reduced exercise capacity, or cognitive symptoms may benefit from assessment and treatment at ferritin levels well above the anemia threshold.
A review in the Swiss Medical Weekly recommends a ferritin cutoff of 30 µg/L for identifying iron deficiency in otherwise healthy adults, even without anemia.5 A patient with ferritin of 18 µg/L is technically within range at most labs and will be told her iron is fine. The published evidence suggests that's not a complete picture.
Vitamin D: 25(OH)D
The standard deficiency cutoff of 20 ng/mL was established around bone health outcomes — specifically, what level was needed to prevent rickets and support calcium absorption. That's a narrow lens. Research has since identified vitamin D receptors in immune cells and the brain, implicating vitamin D status in immune regulation, inflammation, neurodevelopment, and metabolic function.6
"Not deficient" and "replete" are two different states. The standard cutoff doesn't tell you much about where your vitamin D status stands relative to everything else it affects.
Inflammation: hsCRP
High-sensitivity C-reactive protein (hsCRP) is not on most routine annual panels — yet it's one of the more informative markers for cardiovascular risk and inflammatory burden.
The Centers for Disease Control and Prevention and the American Heart Association jointly established a three-tier risk stratification for hsCRP: below 1.0 mg/L represents lower risk; 1.0–3.0 mg/L intermediate; above 3.0 mg/L higher risk.7 That statement has remained the anchor for how hsCRP is used clinically ever since. Many people have never had this marker checked — not because it isn't relevant, but because it wasn't on the standard order.
A Note on What This Is Not
Functional lab interpretation is not a license to pathologize normal variation, over-order tests, or treat numbers without clinical context. The goal is not to find something wrong. It's to ask whether results that are technically acceptable are actually adequate for this person — given their symptoms, history, and life demands.
A functional approach still uses validated reference ranges as a starting point. What changes is the willingness to look at the full picture before a threshold gets crossed. That requires time and clinical judgment — and a conversation that a 15-minute appointment rarely allows for.
What to Do Next
If you've been told your labs are fine but aren't functioning at the level you expect — fatigue that doesn't resolve, sleep disruption, brain fog, mood shifts, exercise intolerance — it may be worth looking more closely at what your results actually say.
Pull your most recent bloodwork. You're legally entitled to a copy. Bring it to your next visit and I'll look at it in the context of your full clinical picture.
Ready to look at your labs in full context?
Book a Discovery CallReferences
- Yang, S., Qiao, R., Li, Z., Wu, Y., Yao, B., et al. (2012). Establishment of reference intervals of 24 chemistries in apparently healthy adult Han population of Northern China. Clinical Biochemistry, 45(15), 1213–1218. https://doi.org/10.1016/j.clinbiochem.2012.06.022
- Zhang, G., Liang, Q., Yang, Y., Leng, P., He, E., & Wang, Y. (2021). Establishment of serum TSH reference intervals by an indirect method for healthy population in Southwest China. Clinical Laboratory, 67(9). https://doi.org/10.7754/Clin.Lab.2021.210101
- Mulla, I. G., Anjankar, A., Pratinidhi, S., Agrawal, S. V., Gundpatil, D., & Lambe, S. D. (2024). Prediabetes: A benign intermediate stage or a risk factor in itself? Cureus, 16(6), e63186. https://doi.org/10.7759/cureus.63186
- Gumus, F., Polat, A., Sinikoglu, S. N., Yektas, A., Erkalp, K., & Alagol, A. (2013). Use of a lower cut-off value for HbA1c to predict postoperative renal complication risk in patients undergoing coronary artery bypass grafting. Journal of Cardiothoracic and Vascular Anesthesia, 27(6), 1167–1173. https://doi.org/10.1053/j.jvca.2013.02.030
- Clénin, G. E. (2017). The treatment of iron deficiency without anaemia (in otherwise healthy persons). Swiss Medical Weekly, 147, w14434. https://doi.org/10.4414/smw.2017.14434
- Eyles, D. W. (2021). Vitamin D: Brain and behavior. JBMR Plus, 5(1), e10419. https://doi.org/10.1002/jbm4.10419
- Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., III, Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., Rifai, N., Smith, S. C., Jr., Taubert, K., Tracy, R. P., & Vinicor, F. (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. Circulation, 107(3), 499–511. https://doi.org/10.1161/01.CIR.0000052939.59093.45